All Roll Calls
Yes: 195 • No: 0
IllinoisHB2874104th General Assembly (2025–2026)HouseWALLET
CONTROLLED SUB-EPHEDRINE
Sponsored By: Martha Deuter (Democratic)
Became Law
health care licensesassignmentspublic health
Your PRIA Score
Score Hidden
Personalized for You
How does this bill affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this bill and every other piece of legislation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Bill Overview
Analyzed Economic Effects
2 provisions identified: 0 benefits, 1 costs, 1 mixed.
Ephedrine marketing claims banned, with penalties
Beginning January 1, 2025, you may not market, advertise, or label ephedrine products for stimulation, mental alertness, weight loss, appetite control, or energy. The state reviews packaging, product name and labels, how you promote or distribute, and spoken claims to check compliance. A first violation is a Class A misdemeanor; a second or later violation is a Class 4 felony. This section does not change the Methamphetamine Precursor Control Act, which still applies.
Over-the-counter ephedrine under strict rules
Beginning January 1, 2025, some ephedrine medicines are exempt from state restrictions in Sections 312 and 313 if they meet strict rules. The product must be legal to sell over the counter, follow 21 C.F.R. § 341.76 labeling, be made to reduce abuse, and not be marketed for stimulation, mental alertness, weight loss, muscle enhancement, appetite control, or energy. Solid pills must follow 21 C.F.R. 341 and be in blister packs with no more than 2 tablets each; anorectal products may have up to 5% ephedrine. Dietary supplements that naturally contain ephedrine remain outside this section if the ephedrine is in an organic matrix and is 15% or less of the product’s weight. Prescription products given by a pharmacy or practitioner under a valid prescription are also outside this section.
Sponsors & Cosponsors
Sponsor
Martha Deuter
Democratic • House
Cosponsors
Bob Morgan
Democratic • House
Hoan Huynh
Democratic • House
Laura Ellman
Democratic • Senate
Mary Edly-Allen
Democratic • Senate
Nicolle Grasse
Democratic • House
Paul Jacobs
Republican • House
Rick Ryan
Democratic • House
Terra Costa Howard
Democratic • House
Theresa Mah
Democratic • House
William E Hauter
Republican • House
Roll Call Votes
Senate vote • 5/22/2025
Third Reading - Passed;
Yes: 58 • No: 0
Senate vote • 4/30/2025
Do Pass Public Health;
Yes: 7 • No: 0
House vote • 4/9/2025
Third Reading - Short Debate - Passed
Yes: 116 • No: 0
House vote • 3/12/2025
Do Pass / Short Debate Health Care Licenses Committee;
Yes: 14 • No: 0
Actions Timeline
Public Act . . . . . . . . . 104-0252
8/15/2025HouseEffective Date January 1, 2026
8/15/2025HouseGovernor Approved
8/15/2025HouseSent to the Governor
6/20/2025HousePassed Both Houses
5/22/2025HouseThird Reading - Passed; 058-000-000
5/22/2025SenateAdded as Alternate Co-Sponsor Sen. Mary Edly-Allen
5/22/2025SenatePlaced on Calendar Order of 3rd Reading **
5/20/2025SenatePlaced on Calendar Order of 3rd Reading May 6, 2025
5/1/2025SenateSecond Reading
5/1/2025SenatePlaced on Calendar Order of 2nd Reading May 1, 2025
4/30/2025SenateDo Pass Public Health; 007-000-000
4/30/2025SenateAssigned to Public Health
4/23/2025SenateReferred to Assignments
4/14/2025SenateFirst Reading
4/14/2025SenateChief Senate Sponsor Sen. Laura Ellman
4/14/2025SenatePlaced on Calendar Order of First Reading
4/10/2025SenateArrive in Senate
4/10/2025SenateAdded Co-Sponsor Rep. Hoan Huynh
4/9/2025HouseThird Reading - Short Debate - Passed 116-000-000
4/9/2025HouseAdded Chief Co-Sponsor Rep. Theresa Mah
4/8/2025HouseAdded Chief Co-Sponsor Rep. Paul Jacobs
4/8/2025HouseAdded Chief Co-Sponsor Rep. William E Hauter
4/8/2025HouseAdded Chief Co-Sponsor Rep. Bob Morgan
4/8/2025HouseAdded Co-Sponsor Rep. Terra Costa Howard
4/8/2025House
Bill Text
Engrossed
Enrolled
Introduced